AXIM Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome With CanChew Plus® Cannabidiol (CBD) Chewing Gum
March 07, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, March 07, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced enrollment of 40 patients...
AXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing Gum
March 01, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, March 01, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, began production of CanChew Plus™, the next...
Elsevier Updates Foundational Reference "Foodborne Diseases," Announces Four Additional Food Science Books
February 16, 2017 04:00 ET
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - February 16, 2017) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of an...
PetLife Pharmaceuticals Announces Son of World Famous Veterinarian & Pet Industry Innovator, Geoffrey Broderick, to Join the Company as the New President
February 03, 2017 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Feb. 03, 2017 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications...
AXIM Biotech Holds Annual Board Meeting
January 25, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 25, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, held its second annual board meeting on...
PetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels.
January 10, 2017 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Jan. 10, 2017 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
Marij Pharmaceuticals, Inc. (“MariJ” or the “Company”), a wholly-owned subsidiary of Acacia Diversified Holdings, Inc. (“Acacia”) (OTCQB symbol: ACCA), begins manufacturing USDA Certified Organic hemp oil.
December 29, 2016 12:30 ET
|
Acacia Diversified Holdings, Inc.
Clearwater, Florida, Dec. 29, 2016 (GLOBE NEWSWIRE) -- MariJ, a certified organic mobile CO2 processor and handler, has entered into a processing agreement with a certified organic hemp farm in...
AXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids' Therapeutic Indications
December 29, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Dec. 29, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in biotechnology cannabinoid research and development, announced today the addition...
AXIM® Biotech Expands Advisory Board With Psychiatry Specialist – Dr. Ilya Reznik
December 13, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, announces the addition to its advisory...
Correction: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 07, 2016 08:50 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Dec. 07, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...